Sanofi

SNYleader

Sanofi is a French multinational pharmaceutical company anchored by blockbuster biologic Dupixent (co-developed with Regeneron) and one of the world's largest vaccine businesses.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($46.1B)

Datos estáticos (cargando finanzas en tiempo real…)

Biopharma (55%)

Vaccines (18%)

General Medicines (18%)

Consumer Healthcare (9%)

Composición de segmentos y clientes principales

Detalles del producto

Dupixent30%

Blockbuster biologic for atopic dermatitis, asthma, and other inflammatory conditions

Vaccines (Sanofi Pasteur)20%

Flu vaccines, pediatric combinations, and Beyfortus (RSV)

General Medicines30%

Lantus insulin, Plavix, and mature drug portfolio

Specialty Care & Consumer20%

Rare disease treatments and consumer healthcare

Relaciones en la Cadena de Suministro

Socios

Regeneron Pharmaceuticals

Dupixent co-development and profit sharing

Impacto: Critical — Regeneron develops key drug

Competidores

Pfizer Inc.

Vaccines and respiratory

Impacto: Medium — vaccine market competition

AstraZeneca

Respiratory and immunology

Impacto: Medium — overlapping therapeutic areas

Contexto macro y de mercado

제약 / 바이오Noticias del sector

GLP-1 메가트렌드 + AI 신약개발 + 저평가 바이오 기관 매집

GLP-1 시장 규모 (2030E)

$150B

mRNA 암백신 임상 성공률

+49% 재발 위험 감소

AI 신약개발 단계

임상 2상 진입

PFE/MRNA 52주 변화

-30% ~ -45%

Próximos catalizadores

◆LLY Orforglipron(경구용 GLP-1) 3상 결과 (2026.Q2)◆MRNA 암백신 FDA BLA 제출 예정◆REGN EYLEA HD 유럽 허가 결과

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de Sanofi impulsado por IA.

Información de la Empresa

Sede Central

Paris, France

Fundación

2004

Empleados

91,000+

Sitio Web

sanofi.com

Estado del sector — 제약 / 바이오

Noticias del sector